Dietary therapies, such as the ketogenic diet, are widely accepted treatments for patients with the GLUT1 deficiency syndrome, while ameliorating certain symptoms associated with GLUT3 deficiency in animal models. The gene discussed is SLC2A3; the disease is hyperinsulinemic hypoglycemia, familial, 4.